R R

What Is Ocular Leishmaniasis?

Ocular leishmaniasis is involvement of the eyelids, conjunctiva, or deeper ocular tissues by infection with Leishmania parasites. These organisms are transmitted by sandfly bites and usually cause cutaneous or visceral disease. When the periocular region is involved, lesions can affect lid skin, lash line, or conjunctiva, and in some cases the cornea, uvea, or optic nerve. The condition is more common in endemic regions but can appear in travelers. Eye involvement can lead to scarring and visual loss if not recognized and treated.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is Ocular Leishmaniasis?

Ocular leishmaniasis is involvement of the eyelids, conjunctiva, or deeper ocular tissues by infection with Leishmania parasites. These organisms are transmitted by sandfly bites and usually cause cutaneous or visceral disease. When the periocular region is involved, lesions can affect lid skin, lash line, or conjunctiva, and in some cases the cornea, uvea, or optic nerve. The condition is more common in endemic regions but can appear in travelers. Eye involvement can lead to scarring and visual loss if not recognized and treated.

read more about ocular leishmaniasis ...

Copy this HTML:

Copy HTML Copied!

Clinical Manifestations Around the Eye

Lid leishmaniasis often presents as a chronic, sometimes ulcerated nodule or plaque near the eyelid margin. Misdiagnosis as chalazion, basal cell carcinoma, or other lid tumors is common. Conjunctival lesions can appear as granulomatous masses or persistent redness and thickening. Corneal and uveal involvement are less frequent but more dangerous for vision, with keratitis or uveitis causing pain, photophobia, and blur. Eyelid scarring can lead to entropion, ectropion, or lagophthalmos that further threaten the ocular surface.

Diagnosis and Systemic Evaluation

Diagnosis requires a high index of suspicion in patients from or visiting endemic areas who present with atypical lid or conjunctival lesions. Confirmation is usually by demonstration of Leishmania parasites in tissue smears, biopsies, or culture, or by molecular methods such as PCR. Serology and systemic assessment help determine whether disease is limited to the skin or part of visceral leishmaniasis. Collaboration with infectious disease specialists is important to plan therapy.

Treatment and Local Eye Care

Treatment depends on the species of Leishmania, disease extent, and patient factors. Systemic therapy with antimonial compounds, amphotericin B, miltefosine, or other agents is often used, especially in mucosal or visceral forms. Local measures such as lubricants, antibiotics for secondary infection, and management of lid malposition protect the eye surface. In some cases, reconstructive lid surgery is needed after infection control. Early treatment can limit tissue destruction and reduce the risk of long term scarring.

Prognosis and Prevention

Prognosis varies with promptness of diagnosis, parasite species, and depth of ocular involvement. Many cutaneous periocular lesions heal with appropriate therapy but can leave cosmetic or functional lid changes. Deep ocular involvement can cause permanent visual damage. Preventive measures in endemic regions include insect bite protection, insecticide treated nets, and control of reservoir hosts. Travelers to such areas are advised to reduce nighttime exposure to sandflies.

FAQs About Ocular Leishmaniasis

Is ocular leishmaniasis contagious from person to person?

No, it is spread by sandfly bites, not by casual contact between people.

Can it be cured with eye drops alone?

Systemic therapy is usually needed; topical treatment alone is not enough for active infection.

Should every lid nodule in endemic areas be tested for leishmaniasis?

Suspicious, chronic, or atypical lesions near the eye often warrant biopsy or testing, especially when common causes do not fit.

Can ocular leishmaniasis come back after treatment?

Relapse can occur, particularly in immunocompromised patients, so follow up with both eye and infectious disease specialists is important.

References

WHO. ?Leishmaniasis.? https://www.who.int/news-room/fact-sheets/detail/leishmaniasis

CDC. ?Leishmaniasis.? https://www.cdc.gov/parasites/leishmaniasis/index.html

PubMed. ?Ocular leishmaniasis (search results).? https://pubmed.ncbi.nlm.nih.gov/?term=ocular+leishmaniasis

PubMed Central (PMC). ?Ocular leishmaniasis (search results).? https://pmc.ncbi.nlm.nih.gov/?term=ocular+leishmaniasis

EyeWiki. ?Leishmaniasis.? https://eyewiki.org/Leishmaniasis